Log in

Amneal Pharmaceuticals SEC Filings & 10K Form (NYSE:AMRX)

$4.91
-0.07 (-1.41 %)
(As of 02/18/2020 04:50 AM ET)
Today's Range
$4.85
Now: $4.91
$5.11
50-Day Range
$4.43
MA: $4.81
$5.36
52-Week Range
$2.27
Now: $4.91
$14.79
Volume710,359 shs
Average Volume966,051 shs
Market Capitalization$1.47 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.76

SEC Filings

Amneal Pharmaceuticals (NYSE:AMRX) SEC Filings

DateFilerForm TypeView
02/14/2020
3:27 PM
Amneal Pharmaceuticals (Issuer)
Todisco Joseph (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/14/2020
5:59 AM
Amneal Pharmaceuticals (Subject)
Fosun International Ltd (Filed by)
Form SC 13G/A
02/12/2020
10:01 AM
Amneal Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/12/2020
6:23 AM
Amneal Pharmaceuticals (Subject)
VANGUARD SPECIALIZED FUNDS (Filed by)
Form SC 13G/A
02/05/2020
10:26 AM
Amneal Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/28/2020
11:05 AM
Amneal Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/23/2020
4:42 PM
Amneal Pharmaceuticals (Issuer)
Branning Todd P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2020
9:32 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
5:08 PM
Amneal Pharmaceuticals (Issuer)
Manzano Stephen (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/06/2020
4:20 PM
Amneal Pharmaceuticals (Issuer)
BUCHEN DAVID A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
4:44 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
4:44 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
4:43 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
4:52 PM
Amneal Pharmaceuticals (Issuer)
George Jeffrey P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2019
4:51 PM
Amneal Pharmaceuticals (Issuer)
Kiely John (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2019
4:51 PM
Amneal Pharmaceuticals (Issuer)
Yanai Shlomo (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2019
3:50 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
3:51 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
1:18 PM
Amneal Pharmaceuticals (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
11/14/2019
4:27 PM
Amneal Pharmaceuticals (Issuer)
Todisco Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2019
4:27 PM
Amneal Pharmaceuticals (Issuer)
Shah Nikita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2019
4:26 PM
Amneal Pharmaceuticals (Issuer)
Bhadauria Pradeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2019
4:26 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2019
4:26 PM
Amneal Pharmaceuticals (Issuer)
Branning Todd P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
5:54 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2019
3:35 PM
Amneal Pharmaceuticals (Filer)
Form DEF 14C
10/11/2019
3:42 PM
Amneal Pharmaceuticals (Filer)
Form PRE 14C
10/11/2019
11:07 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2019
4:14 PM
Amneal Pharmaceuticals (Subject)
Patel Chirag K. (Filed by)
Form SC 13D/A
09/10/2019
11:13 AM
Amneal Pharmaceuticals (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
08/28/2019
3:53 PM
Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2019
4:27 PM
Amneal Pharmaceuticals (Subject)
Patel Tushar Bhikhubhai (Filed by)
Form SC 13D/A
08/26/2019
4:27 PM
Amneal Pharmaceuticals (Subject)
Patel Gautam (Filed by)
Form SC 13D/A
08/19/2019
8:03 PM
Amneal Pharmaceuticals (Issuer)
Bhadauria Pradeep (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2019
5:15 AM
Amneal Pharmaceuticals (Issuer)
Fosun International Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
3:32 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
7:58 AM
Amneal Pharmaceuticals (Issuer)
Fosun International Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
7:39 PM
Amneal Pharmaceuticals (Subject)
Patel Chirag K. (Filed by)
Form SC 13D/A
08/06/2019
7:37 PM
Amneal Pharmaceuticals (Subject)
Patel Chintu (Filed by)
Form SC 13D/A
08/06/2019
3:19 PM
Amneal Pharmaceuticals (Issuer)
MEISTER PAUL M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/05/2019
3:39 PM
Amneal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2019
5:20 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2019
5:13 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2019
3:51 PM
Amneal Pharmaceuticals (Subject)
TPG Group Holdings Advisors, Inc. (0001495741) (Filed by)
Form SC 13D/A
07/19/2019
3:47 PM
Amneal Pharmaceuticals (Issuer)
BONDERMAN DAVID (Reporting)
COULTER JAMES G (Reporting)
TPG Group Holdings Advisors, Inc. (0001495741) (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2019
3:52 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2019
4:27 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2019
4:27 PM
Amneal Pharmaceuticals (Issuer)
Todisco Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
4:45 PM
Amneal Pharmaceuticals (Issuer)
Todisco Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
4:44 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
4:43 PM
Amneal Pharmaceuticals (Issuer)
BISARO PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
4:43 PM
Amneal Pharmaceuticals (Issuer)
Stewart Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
4:42 PM
Amneal Pharmaceuticals (Issuer)
Shah Nikita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
3:43 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:16 PM
Amneal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
5:42 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
4:50 PM
Amneal Pharmaceuticals (Issuer)
BUCHI J KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
4:49 PM
Amneal Pharmaceuticals (Issuer)
Patel Gautam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
4:49 PM
Amneal Pharmaceuticals (Issuer)
Patel Chintu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
4:48 PM
Amneal Pharmaceuticals (Issuer)
Rama Dharmendra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
4:48 PM
Amneal Pharmaceuticals (Issuer)
Nark Ted C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
4:47 PM
Amneal Pharmaceuticals (Issuer)
BURR ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
4:47 PM
Amneal Pharmaceuticals (Issuer)
Vergis Janet S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
4:46 PM
Amneal Pharmaceuticals (Issuer)
TERRERI PETER R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
4:46 PM
Amneal Pharmaceuticals (Issuer)
Greene Jean Selden (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
4:45 PM
Amneal Pharmaceuticals (Issuer)
Patel Chirag K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
4:45 PM
Alva Emily Peterson (Reporting)
Amneal Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2019
5:14 PM
Amneal Pharmaceuticals (Issuer)
Bhadauria Pradeep (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/07/2019
5:12 PM
Amneal Pharmaceuticals (Issuer)
Todisco Joseph (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/22/2019
3:20 PM
Amneal Pharmaceuticals (Filer)
Form DEFA14A
03/22/2019
3:19 PM
Amneal Pharmaceuticals (Filer)
Form DEF 14A
03/12/2019
3:49 PM
Amneal Pharmaceuticals (Issuer)
Stewart Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2019
3:45 PM
Amneal Pharmaceuticals (Issuer)
BISARO PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2019
4:41 PM
Amneal Pharmaceuticals (Issuer)
TERRERI PETER R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
5:04 PM
Amneal Pharmaceuticals (Issuer)
Stewart Robert A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
5:02 PM
Amneal Pharmaceuticals (Issuer)
Shah Nikita (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
5:01 PM
Amneal Pharmaceuticals (Issuer)
BOYER ANDREW S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
3:28 PM
Amneal Pharmaceuticals (Filer)
Form S-3ASR
03/01/2019
9:27 AM
Amneal Pharmaceuticals (Filer)
Form POSASR
03/01/2019
7:55 AM
Amneal Pharmaceuticals (Filer)
Form 8-K/A
03/01/2019
7:31 AM
Amneal Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2019
7:02 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2019
8:42 AM
Amneal Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/31/2019
2:11 PM
Amneal Pharmaceuticals (Subject)
VANGUARD SPECIALIZED FUNDS (Filed by)
Form SC 13G
01/24/2019
4:45 PM
Amneal Pharmaceuticals (Issuer)
Branning Todd P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
3:25 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2019
3:18 PM
Amneal Pharmaceuticals (Issuer)
Branning Todd P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/16/2019
4:16 PM
Amneal Pharmaceuticals (Issuer)
BURR ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
8:14 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2019
4:56 PM
Amneal Pharmaceuticals (Issuer)
BUCHEN DAVID A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2019
3:35 PM
Amneal Pharmaceuticals (Issuer)
BUCHEN DAVID A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/07/2018
3:24 PM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
4:03 PM
Amneal Pharmaceuticals (Filer)
Form 424B3
11/13/2018
12:13 PM
Amneal Pharmaceuticals (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G
11/13/2018
7:07 AM
Amneal Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/07/2018
3:51 PM
Amneal Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2018
6:02 AM
Amneal Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2018
9:48 AM
Ambient Impact Ltd (0001754569) (Reporting)
Amneal Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/28/2018
9:46 AM
Amneal Pharmaceuticals (Issuer)
Fosun International Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/28/2018
9:42 AM
Amneal Pharmaceuticals (Subject)
Fosun International Ltd (Filed by)
Form SC 13G/A
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Featured Article: Depreciation

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel